107
Views
15
CrossRef citations to date
0
Altmetric
Original Research

The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation

, , , , , , , , , , , , , & show all
Pages 6185-6199 | Published online: 04 Jul 2019

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-31091226818619
  • Kallini JR, Gabr A, Abouchaleh N, et al. New developments in interventional oncology: liver metastases from colorectal cancer. Cancer J. 2016;22(6):373–380. doi:10.1097/PPO.000000000000022627870679
  • Gruber-Rouh T, Marko C, Thalhammer A, et al. Current strategies in interventional oncology of colorectal liver metastases. Br J Radiol. 2016;89:20151060. doi:10.1259/bjr.2015106027164030
  • Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540–555. doi:10.1038/nrc398226289314
  • Kim YJ, Varki A. Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J. 1997;14(5):569–576.9298689
  • Zhao Y, Li Y, Ma H, et al. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma. Mol Cell Proteomics. 2014;13(2):520–536. doi:10.1074/mcp.M113.03402524255131
  • Recchi MA, Hebbar M, Hornez L, Harduin-Lepers A, Peyrat JP, Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 1998;58(18):4066–4070.9751611
  • Wang PH, Li YF, Juang CM, et al. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol Oncol. 2001;83(1):121–127. doi:10.1006/gyno.2001.635811585423
  • Dall’Olio F, Malagolini N, Di Stefano G, Minni F, Marrano D, Serafini-Cessi F. Increased CMP-NeuAc: Galbeta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human colorectal cancer tissues. Int J Cancer. 1989;44(3):434–439.2476402
  • Lu J, Gu J. Significance of beta-Galactoside alpha2,6 Sialyltranferase 1 in Cancers. Molecules. 2015;20(5):7509–7527. doi:10.3390/molecules2005750925919275
  • Isaji T, Im S, Gu W, et al. An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation. J Biol Chem. 2014;289(30):20694–20705. doi:10.1074/jbc.M113.54268824895123
  • Vierbuchen MJ, Fruechtnicht W, Brackrock S, Krause KT, Zienkiewicz TJ. Quantitative lectin-histochemical and immunohistochemical studies on the occurrence of alpha(2,3)- and alpha(2,6)-linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features. Cancer. 1995;76(5):727–735.8625173
  • Zhang Z, Sun J, Hao L, Liu C, Ma H, Jia L. Modification of glycosylation mediates the invasive properties of murine hepatocarcinoma cell lines to lymph nodes. PLoS One. 2013;8(6):e65218. doi:10.1371/journal.pone.006521823840320
  • Lin S, Kemmner W, Grigull S, Schlag PM. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002;276(1):101–110. doi:10.1006/excr.2002.552111978012
  • Zhu Y, Srivatana U, Ullah A, Gagneja H, Berenson CS, Lance P. Suppression of a sialyltransferase by antisense DNA reduces invasiveness of human colon cancer cells in vitro. Biochim Biophys Acta. 2001;1536(2–3):148–160.11406350
  • Christie DR, Shaikh FM, Lucas J, Lucas JA 3rd, Bellis SL. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res. 2008;1(1):3. doi:10.1186/1757-2215-1-319014651
  • Zhang S, Lu J, Xu Z, et al. Differential expression of ST6GAL1 in the tumor progression of colorectal cancer. Biochem Biophys Res Commun. 2017;486(4):1090–1096. doi:10.1016/j.bbrc.2017.03.16728377225
  • Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988;52(6):925–933.3349522
  • Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med. 2000;28(9):1379–1386.10924857
  • Springer TA. Adhesion receptors of the immune system. Nature. 1990;346(6283):425–434. doi:10.1038/346425a01974032
  • Hamai A, Meslin F, Benlalam H, et al. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. Cancer Res. 2008;68(23):9854–9864. doi:10.1158/0008-5472.CAN-08-071919047166
  • Lin YC, Shun CT, Wu MS, Chen CC. A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kappaB. Clin Cancer Res. 2006;12(23):7165–7173. doi:10.1158/1078-0432.CCR-06-139317145842
  • Brooks KJ, Coleman EJ, Vitetta ES. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer. 2008;123(10):2438–2445. doi:10.1002/ijc.2379318752248
  • Liang S, Slattery MJ, Wagner D, Simon SI, Dong C. Hydrodynamic shear rate regulates melanoma-leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasation. Ann Biomed Eng. 2008;36(4):661–671. doi:10.1007/s10439-008-9445-818253835
  • Wang S, Coleman EJ, Pop LM, Brooks KJ, Vitetta ES, Niederkorn JY. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. Int J Cancer. 2006;118(4):932–941. doi:10.1002/ijc.2128916152588
  • Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 1991;147(12):4398–4401.1684377
  • Alexiou D, Karayiannakis AJ, Syrigos KN, et al. Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal cancer patients: correlations with clinicopathological features, patient survival and tumour surgery. Eur J Cancer. 2001;37(18):2392–2397.11720833
  • Toiyama Y, Miki C, Inoue Y, et al. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients. Ann Surg Oncol. 2008;15(6):1617–1624. doi:10.1245/s10434-008-9874-518368454
  • Zou X, Feng B, Dong T, et al. Up-regulation of type I collagen during tumorigenesis of colorectal cancer revealed by quantitative proteomic analysis. J Proteomics. 2013;94:473–485. doi:10.1016/j.jprot.2013.10.02024332065
  • Zhang L, Syed ZA, van Dijk Hard I, Lim JM, Wells L, Ten Hagen KG. O-glycosylation regulates polarized secretion by modulating Tango1 stability. Proc Natl Acad Sci U S A. 2014;111(20):7296–7301. doi:10.1073/pnas.132226411124799692
  • Schjoldager KT, Clausen H. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. Biochim Biophys Acta. 2012;1820(12):2079–2094. doi:10.1016/j.bbagen.2012.09.01423022508
  • Becker JC, Termeer C, Schmidt RE, Brocker EB. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol. 1993;151(12):7224–7232.7903103
  • Makgoba MW, Sanders ME, Ginther Luce GE, et al. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity. Eur J Immunol. 1988;18(4):637–640. doi:10.1002/eji.18301804232896596
  • Chong AS, Boussy IA, Jiang XL, Lamas M, Graf LH Jr. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol. 1994;157(1):92–105. doi:10.1006/cimm.1994.12087518755
  • Sanchez-Rovira P, Jimenez E, Carracedo J, Barneto IC, Ramirez R, Aranda E. Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer. 1998;34(3):394–398.9640229
  • Araki T, Miki C, Kusunoki M. Biological implications of circulating soluble intercellular adhesion molecule-1 in colorectal cancer patients. Scand J Gastroenterol. 2001;36(4):399–404.11336165
  • Reis CA, Osorio H, Silva L, Gomes C, David L. Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol. 2010;63(4):322–329. doi:10.1136/jcp.2009.07103520354203
  • Park JJ, Yi JY, Jin YB, et al. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol. 2012;83(7):849–857. doi:10.1016/j.bcp.2012.01.00722266356
  • Basoglu M, Atamanalp SS, Yildirgan MI, et al. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res. 2007;39(3):136–140. doi:10.1159/00010011017337890
  • Qian J, Zhu CH, Tang S, et al. alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells. Acta Pharmacol Sin. 2009;30(7):1039–1045. doi:10.1038/aps.2009.8419483716
  • Yen HY, Liu YC, Chen NY, et al. Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition. Proc Natl Acad Sci U S A. 2015;112(22):6955–6960. doi:10.1073/pnas.150732911225971727
  • Yang M, Liu J, Piao C, Shao J, Du J. ICAM-1 suppresses tumor metastasis by inhibiting macrophage M2 polarization through blockade of efferocytosis. Cell Death Dis. 2015;6:e1780. doi:10.1038/cddis.2015.14426068788
  • Danguy A, Camby I, Kiss R. Galectins and cancer. Biochim Biophys Acta. 2002;1572(2–3):285–293.12223276
  • Kimura N, Ohmori K, Miyazaki K, et al. Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J Biol Chem. 2007;282(44):32200–32207. doi:10.1074/jbc.M70234120017728258
  • Woodard-Grice AV, McBrayer AC, Wakefield JK, Zhuo Y, Bellis SL. Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins. J Biol Chem. 2008;283(39):26364–26373. doi:10.1074/jbc.M80083620018650447
  • Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J Biol Chem. 2003;278(9):7469–7475. doi:10.1074/jbc.M20959520012499376
  • Kitazume S, Imamaki R, Ogawa K, et al. Alpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling. J Biol Chem. 2010;285(9):6515–6521. doi:10.1074/jbc.M109.07310620048157
  • Swindall AF, Bellis SL. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem. 2011;286(26):22982–22990. doi:10.1074/jbc.M110.21137521550977
  • Erturk K, Tastekin D, Bilgin E, Serilmez M, Bozbey HU, Sakar B. Serum activated leukocyte cell adhesion molecule and intercellular adhesion molecule-1 in patients with gastric cancer: can they be used as biomarkers? Biomed Pharmacother. 2016;77:86–91. doi:10.1016/j.biopha.2015.12.00626796270
  • Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw. 2004;15(2):91–98.15319166